116 related articles for article (PubMed ID: 21965980)
1. Trihexyphenidyl dependence-report of two cases.
Michael A; Murali T; Mathai PJ; Gopinath PS
Indian J Psychiatry; 1984 Apr; 26(2):178-9. PubMed ID: 21965980
[TBL] [Abstract][Full Text] [Related]
2. Trihexyphenidyl dependence.
McInnis M; Petursson H
Acta Psychiatr Scand; 1984 Jun; 69(6):538-42. PubMed ID: 6741602
[TBL] [Abstract][Full Text] [Related]
3. High dose trihexyphenidyl abuse with psychological dependence.
Sofair J; Campion J; Angrist B
J Clin Psychopharmacol; 1983 Aug; 3(4):263-4. PubMed ID: 6886042
[No Abstract] [Full Text] [Related]
4. Trihexyphenidyl abuse in schizophrenic patient: a case report.
Lo Y; Tsai SJ
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):157-60. PubMed ID: 8634932
[TBL] [Abstract][Full Text] [Related]
5. [Effect of trihexyphenidyl-HCL on posttraumatic prolonged disturbance of consciousness: report of two cases].
Kaijima M; Fukuda H; Tomabechi M; Hodozuka A
No Shinkei Geka; 1989 May; 17(5):467-71. PubMed ID: 2779731
[TBL] [Abstract][Full Text] [Related]
6. Crossover clinical trial of benapryzine and trihexyphenidyl in Parkinsonian patients.
Lamid S; Jenkins RB
J Clin Pharmacol; 1975; 15(8-9):622-6. PubMed ID: 1097479
[TBL] [Abstract][Full Text] [Related]
7. [Misuse of trihexyphenidyl (Artane, Parkinane): recent trends].
Frauger E; Thirion X; Chanut C; Natali F; Debruyne D; Saillard C; Pradel V; Reggio P; Micallef J
Therapie; 2003; 58(6):541-7. PubMed ID: 15058500
[TBL] [Abstract][Full Text] [Related]
8. Trihexyphenidyl (Artane) dependence: A controlled investigation between users and abusers.
Qureshi NA; Al Amri AH; Abdelgadir MH; El-Haraka EA
Ann Saudi Med; 1997 Mar; 17(2):185-90. PubMed ID: 17377427
[TBL] [Abstract][Full Text] [Related]
9. A CRITICAL ANALYSIS OF THE EFFECTS OF TRIHEXYPHENIDYL (ARTANE) ON THE COMPONENTS OF THE PARKINSONIAN SYNDROME.
BRUMLIK J; CANTER G; DELATORRE R; MIER M; PETROVICK M; BOSHES B
J Nerv Ment Dis; 1964 May; 138():424-31. PubMed ID: 14147023
[No Abstract] [Full Text] [Related]
10. Trihexyphenidyl Misuse in Delusional Disorder.
Mahal P; Nishanth KN; Mahapatra A; Sarkar S; Balhara YPS
J Neurosci Rural Pract; 2018; 9(3):428-430. PubMed ID: 30069107
[TBL] [Abstract][Full Text] [Related]
11. A COMPARATIVE STUDY OF TRIHEXYPHENIDYL (ARTANE) AND ORPHENADRINE (DISIPAL) IN THE TREATMENT OF GERIATRIC PARKINSONISM.
STRANG RR
J Am Geriatr Soc; 1965 Aug; 13():756-9. PubMed ID: 14322547
[No Abstract] [Full Text] [Related]
12. THE PARKINSONIAN SYNDROME. PROGNOSIS AND TREATMENT.
SILVERSIDES JL
Postgrad Med; 1965 Apr; 37():440-5. PubMed ID: 14265378
[No Abstract] [Full Text] [Related]
13. Quantitation of trihexyphenidyl from plasma using a mass-selective detector and electron-impact ionization.
Desage M; Rousseau-Tsangaris M; Lecompte D; Brazier JL
J Chromatogr; 1991 Nov; 571(1-2):250-6. PubMed ID: 1810953
[TBL] [Abstract][Full Text] [Related]
14. DRUGS FOR PARKINSONISM.
RICHARDSON JC
Can Med Assoc J; 1965 Apr; 92(17):928-9. PubMed ID: 14289143
[No Abstract] [Full Text] [Related]
15. ANTI-PARKINSONISM DRUG THERAPY.
FRIEND DG
Clin Pharmacol Ther; 1963; 4():815-22. PubMed ID: 14079254
[No Abstract] [Full Text] [Related]
16. Trihexyphenidyl; evaluation of the new agent in the treatment of Parkinsonism.
CORBIN KB
J Am Med Assoc; 1949 Oct; 141(6):377-82. PubMed ID: 18140656
[No Abstract] [Full Text] [Related]
17. EFFECTS OF TRIHEXYPHENIDYL HYDROCHLORIDE (ARTANE) ON PARKINSON'S DISEASE.
BURNS BD; DEJONG D; SOLIS-QUIROGA OH
Neurology; 1964 Jan; 14():13-23. PubMed ID: 14112442
[No Abstract] [Full Text] [Related]
18. Sustained improvement of motor function in hemiparkinsonian rats chronically treated with low doses of caffeine or trihexyphenidyl.
Bata-García JL; Villanueva-Toledo J; Gutiérrez-Ospina G; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
Pharmacol Biochem Behav; 2007 Jan; 86(1):68-78. PubMed ID: 17250882
[TBL] [Abstract][Full Text] [Related]
19. Trihexyphenidyl dependence.
Appaya MP
J Assoc Physicians India; 1985 Dec; 33(12):817, 819. PubMed ID: 3837009
[No Abstract] [Full Text] [Related]
20. Effect of anticholinergic drugs on gastro-intestinal absorption of L-dopa in rats and in man.
Algeri S; Cerletti C; Curcio M; Morselli PL; Bonollo L; Buniva G; Minazzi M; Minoli G
Eur J Pharmacol; 1976 Feb; 35(2):293-9. PubMed ID: 1248506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
